Mode
Text Size
Log in / Sign up
Phase 4 Completed N=122 Randomized Triple-blind Treatment

Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department

Source: ClinicalTrials.gov NCT02760069 ↗
Enrolled (actual)
122
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcomePrimary: Nausea 100 mm Visual Analogue Scale (VAS) — 23; 19; 42 units on a scale
◆ Published Evidence
Established
39citations · ~5 / year
Aromatherapy Versus Oral Ondansetron for Antiemetic Therapy Among Adult Emergency Department Patients: A Randomized Controlled Trial.
Annals of emergency medicine · 2018 · Likely link

Summary

This study will compare the efficacy of isopropyl alcohol and conventional anti-emetics with three study arms: (1) inhaled isopropyl alcohol plus oral ondansetron; (2) inhaled isopropyl alcohol plus oral placebo; (3) inhaled placebo plus oral ondansetron.

Linked Publications

  • Aromatherapy Versus Oral Ondansetron for Antiemetic Therapy Among Adult Emergency Department Patients: A Randomized Controlled Trial.
    Annals of emergency medicine · 2018 · 39 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Nausea 100 mm Visual Analogue Scale (VAS)
23; 19; 42
SECONDARY
Number of Participants Who Required Rescue Anti-emetics
11; 10; 18

Eligibility Criteria

Inclusion Criteria

  • ages 18 and older
  • complaint of nausea and/or vomiting reported at 3 or above on verbal numerical rating scale at the time of triage

Exclusion Criteria

  • allergy to isopropyl alcohol or ondansetron
  • inability to breathe through nose (e.g., recent upper respiratory infection)
  • intake of cefoperazone, disulfiram, or metronidazole within the last 24 hours
  • mental status precluding informed consent including intoxication
  • known QT-prolongation
  • clinical suspicion for serotonin syndrome
  • intravenous catheter in place prior to study start
  • medications administered since patient arrival (e.g., in triage)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02760069) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search